Lingua

STORIA - L’ESPERIENZA FA LA DIFFERENZA

MISSION - MASSIMA LIBERTÀ DI SCELTA PER IL PAZIENTE

STRUTTURA - UN CONCENTRATO DI PURA EFFICIENZA

SERVIZI - TUTTI I VANTAGGI DI ESSERE PARTNER

Swissmedic approves Roche drug Perjeta for patients with breast cancer

18/02/2013

New personalised drug confers longer progression-free survival on patients with previously untreated HER2-positive metastatic breast cancer

Removab

28/01/2013

Destruction of cancer cells through a trifunctional antibody

FDA expands Zytiga’s use for late-stage prostate cancer

25/01/2013

Drug can now be used before treatment with chemotherapy

Kalydeco

14/12/2012

A new oral medication for the treatment of cystic fibrosis

Yervoy

14/12/2012

First Drug to Extend Survival in Late-Stage Skin Cancer

Plenadren approved for treatment of Adrenal Insufficiency (AI)

03/12/2012

ViroPharma Announces The First EU Market To Launch Plenadren® (Hydrocortisone, Modified-Release Tablet) For Treatment Of Adrenal Insufficiency, The First New Treatment Innovation For Over 50 Years

Bayer’s Novel Anticoagulant Xarelto® now also Approved in the EU

02/11/2008

Bayer will start marketing the new oral, once-daily anticoagulant very soon / First-in-class product to demonstrate superior efficacy to current standard of care

PRILOCAINE HYPERBAR SINTETICA in esclusiva per l'Italia

28/10/2008

A partire dal 01 novembre 2008 Unipharma SA distribuirà in esclusiva in Italia il prodotto:

PRILOCAINE HYPERBAR SINTETICA 2% 10 fiale 5 ml

Jerini Receives European Commission Approval for Firazyr (Icatibant) in the Treatment...

Jerini Receives European Commission Approval for Firazyr (Icatibant) in the Treatment of HAE

Diventa fornitore unipharma

Inserito da admin il Dom, 08/24/2008 - 18:13

Diventa cliente unipharma

Inserito da admin il Dom, 08/24/2008 - 17:55

FDA Approves Kinrix - New Combination Vaccine for Children

07/07/2008

GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine], the first combination vaccine to offer protection against diphtheria, tetanus, pertussis and polio diseases in one shot.

Acquisizione di Pharmion da parte di Celgene

07/07/2008

Celgene Corporation ha comunicato in data 11 marzo 2008 il completamento dell'acquisizione, del valore di 2.9 miliardi di dollari, di Pharmion Corporation.

RSS

Archivio News

Diventa Cliente Unipharma

Diventa Fornitore Unipharma